Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate

PURPOSE: The principal objective of this trial was to evaluate the antitumor activity of abiraterone acetate, an oral, specific, irreversible inhibitor of CYP17 in docetaxel-treated patients with castration-resistant prostate cancer (CRPC). PATIENTS AND METHODS: In this multicenter, two-stage, phase...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Reid, Alison H.M., Attard, Gerhardt, Danila, Daniel C., Oommen, Nikhil Babu, Olmos, David, Fong, Peter C., Molife, L. Rhoda, Hunt, Joanne, Messiou, Christina, Parker, Christopher, Dearnaley, David, Swennenhuis, Joost F., Terstappen, Leon W.M.M., Lee, Gloria, Kheoh, Thian, Molina, Arturo, Ryan, Charles J., Small, Eric, Scher, Howard I., de Bono, Johann S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2010
Onderwerpen:
Original Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2849770/
https://ncbi.nlm.nih.gov/pubmed/20159823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.6819
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items